The product approval for Bactiguard's endotracheal tubes has been announced by the Indian Ministry of Health & Family Welfare. This means that Bactiguard can offer its complete portfolio of products for effective and safe infection prevention in one of the largest and fastest growing markets in the world. The Central Drugs Standard Control...
The Annual General Meeting of Bactiguard Holding AB (publ) will be held on Wednesday 16 May, 2018 in Botkyrka. In accordance with the instructions for the Nomination Committee in Bactiguard Holding AB (publ), the Nomination Committee shall consist of four members. The chairman of the Board of Directors shall contact the three largest...
A recently published clinical study* conducted at the Karolinska University Hospital in Sweden shows that Bactiguard’s infection prevention central venous catheter – BIP CVC had significantly fewer adverse events compared to a standard uncoated CVC. The study also shows that Bactiguard's noble metal alloy does not expose patients or the...
Bactiguard Holding AB (publ) publishes the interim report for the third quarter on Thursday, November 9, 2017 at 8:00 CET. In connection with this, a conference call for investors, analysts and media will be held at 10:00 CET on November 9. CEO Christian Kinch and CFO Cecilia Edström will present the interim report and answer questions. The...
Bactiguard has entered a partnership with Neon Laboratories Limited (“Neon”) for the north, west and east zones of India, covering a majority of the Indian population. The Neon Group is a family-owned, manufacturer and distributor of pharmaceuticals and medical devices, with a turnover of more than 85 MUSD. The company started operations in...
Bactiguard has won a tender for urinary catheters for the Västra Götaland region (VGR) in Sweden, which enables healthcare providers in both primary and secondary care and 49 municipalities in the region to purchase Bactiguards’ urinary catheters for infection prevention. The contract is valid for 2 years and can be extended for another 2...
The Hong Kong product approval for Bactiguard's central venous catheters for infection prevention has been announced by the Medical Device Control Office. Hong Kong is a small, but strategically important market, as it serves as a reference for new approvals and market acceptance in neighbouring China. The Medical Device Control Office in Hong...
Bactiguard Holding AB (publ) publishes the interim report for the second quarter on Thursday, August 10, 2017 at 8:00 CET. In connection with this, a conference call for investors, analysts and media will be held at 10:00 CET on August 10. CEO Christian Kinch and CFO Fredrik Järrsten will present the interim report and answer questions. The...
Good to Great Tennis Academy and Swedish medtech company Bactiguard AB have today announced that they are continuing to strengthen the development of future tennis talent in Sweden by focusing on younger players between 13 to 14 years of age. Together, Good to Great Tennis Academy and Bactiguard have created a new Team Bactiguard consisting of...
Bactiguard has won a tender for urinary catheters for the southern region (Region Skåne) in Sweden, which enables healthcare providers in both primary and secondary care to purchase Bactiguards’ anti-infective urinary catheters from 1 August 2017. The contract initially runs until 30 April 2018 and can be extended on an annual basis until 30...
Bactiguard has entered partnership with Surgical Innovations Pty Ltd (“SI”), a company within the Medical arm of Ascendis Health, the JNB listed healthcare giant and leading supplier to the healthcare sector in South Africa. “Surgical Innovations is a leading provider of medical devices to both public and private hospitals, representing...
Bactiguard has entered partnership with Gada Italia Srl (“Gada”), a specialized and leading distributor of medical devices and integrated healthcare services. “The Gada group is a leading provider of integrated healthcare solutions to the public and private hospitals in Italy and we are confident that they have the competence and...
Bactiguard has won a tender for urinary catheters for the Stockholm county council, which enables healthcare providers in both primary and secondary care to purchase Bactiguards’ anti-infective urinary catheters. The contract is valid for 2 years and can be extended for another 2 years. "The Stockholm county council is Sweden’s largest region...
At Bactiguard Holding AB’s (publ) Annual General Meeting on May 18, the following resolutions were made: The Annual General Meeting adopted the income statement and balance sheet for 2016. It was decided that no dividend for the financial year 2016 will be paid and that the company's loss (for the year) will be carried forward. The Board of...
Bactiguard signs distribution agreement and enters partnership with Biodina for Brazil. “Biodina has a very strong track record of successfully introducing new and advanced products on the Brazlian market and we are very happy to have them as our partner. We have not been satisfied with the development of Bactiguard sales in Brazil and we...
Bactiguard Holding AB (publ) publishes the interim report for the first quarter on Thursday, May 4, 2017 at 8:00 CET. In connection with this, a conference call for investors, analysts and media will be held at 10:00 CET on May 4. CEO Christian Kinch and CFO Fredrik Järrsten will present the interim report and answer questions. The report and a...
The annual report for Bactiguard Holding AB (publ) 2016 is now available at www.bactiguard.com The annual report is available as a downloadable PDF document in both Swedish and English. A printed version of the report will be available from May 5 and can be ordered at info@bactiguard.se. This information is information that Bactiguard Holding AB...
The shareholders of Bactiguard Holding AB (publ), company reg. no. 556822-1187 (“Bactiguard”) are hereby given notice to attend the Annual General Meeting to be held on Thursday, 18 May 2017 at 2:00 PM at the company´s office at Alfred Nobels Allé 150 in Tullinge. Registration commences at 1 PM. Right to participate and notice of intent to...
Bactiguard has won a tender for urinary catheters covering the Swedish county Kalmar. The contract is an extension of the previous agreement, lasts for 4 years and enables healthcare providers to purchase Bactiguards’ anti-infective urinary catheters. "The Kalmar region has been using our products for the last 2 years and recently decided to...
A recent, independent clinical study conducted in Hong Kong confirms that Bactiguard-coated Foley catheters reduce symptomatic catheter associated urinary tract infections and that the effect is even more pronounced among long-term users. ”Given our recent market entry into China and Hong Kong we are pleased that the study confirms previously...
Bactiguard Holding AB (publ) publishes the year end report for 2016 on Thursday, February 9, 2017 at 8:00 CET. In connection with this, a conference call for investors, analysts and media will be held at 10:00 CET on February 9. CEO Christian Kinch and CFO Fredrik Järrsten will present the report and answer questions. The year end...
Bactiguard signs distribution agreement and enters partnership with Heal Pharma for Egypt. The product registration has been initiated and market launch is planned for the second quarter of 2017. “Egypt is the most populous country in the Arab world, with major challenges in the healthcare sector. We are convinced that...
